2,147
Views
4
CrossRef citations to date
0
Altmetric
Research Article

PI3K/AKT/SERBP-1 pathway regulates Alisma orientalis beverage treatment of atherosclerosis in APOE−/− high-fat diet mice

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 473-487 | Received 06 Jul 2022, Accepted 09 Jan 2023, Published online: 24 Feb 2023

References

  • Aljabban J, Rohr M, Syed S, Khorfan K, Borkowski V, Aljabban H, Segal M, Mukhtar M, Mohammed M, Panahiazar M, et al. 2022. Transcriptome changes in stages of non-alcoholic fatty liver disease. World J Hepatol. 14(7):1382–1397.
  • Aryal A, Harmon AC, Dugas TR. 2021. Particulate matter air pollutants and cardiovascular disease: strategies for intervention. Pharmacol Ther. 223:107890.
  • Barboza LN, Lívero FA, Prando TB, Ribeiro Rde C, Lourenço EL, Budel JM, de Souza LM, Acco A, Dalsenter PR, Gasparotto AJ. 2016. Atheroprotective effects of Cuphea carthagenensis (Jacq.) J. F. Macbr. in New Zealand rabbits fed with cholesterol-rich diet. J Ethnopharmacol. 187:134–145.
  • Chen Y, Yang W, Guo L, Wu X, Zhang T, Liu J, Zhang J. 2017. Atractylodes lactone compounds inhibit platelet activation. Platelets. 28(2):194–202.
  • Francis GA. 2010. The complexity of HDL. Biochim Biophys Acta. 1801(12):1286–1293.
  • Ge L, Liu D, Mao X, Liu S, Guo J, Hou L, Chen X, Huang K. 2022. Low dose of deoxynivalenol aggravates intestinal inflammation and barrier dysfunction induced by enterotoxigenic Escherichia coli infection through activating macroautophagy/NLRP3 inflammasomes. J Agric Food Chem. 70(9):3009–3022.
  • Geovanini GR, Libby P. 2018. Atherosclerosis and inflammation: overview and updates. Clin Sci. 132(12):1243–1252.
  • Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA. 2005. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 33(Database issue):D514–517.
  • Hopkins AL. 2008. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 4(11):682–690.
  • Huang H, He Y, Li Y, Gu M, Wu M, Ji L. 2022. Eriodictyol suppresses the malignant progression of colorectal cancer by downregulating tissue specific transplantation antigen P35B (TSTA3) expression to restrain fucosylation. Bioengineered. 13(3):5551–5563.
  • Jaquish CE, Mahaney MC, Blangero J, Haffner SM, Stern MP, MacCluer JW. 1996. Genetic correlations between lipoprotein phenotypes and indicators of sex hormone levels in Mexican Americans. Atherosclerosis. 122(1):117–125.
  • Jeon TI, Osborne TF. 2012. SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol Metab. 23(2):65–72.
  • Jia CY, Li JY, Hao GF, Yang GF. 2020. A drug-likeness toolbox facilitates ADMET study in drug discovery. Drug Discov Today. 25(1):248–258.
  • Jin HG, Jin Q, Ryun Kim A, Choi H, Lee JH, Kim YS, Lee DG, Woo ER. 2012. A new triterpenoid from Alisma orientale and their antibacterial effect. Arch Pharm Res. 35(11):1919–1926.
  • Karasawa T, Takahashi A, Saito R, Sekiya M, Igarashi M, Iwasaki H, Miyahara S, Koyasu S, Nakagawa Y, Ishii K, et al. 2011. Sterol regulatory element-binding protein-1 determines plasma remnant lipoproteins and accelerates atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol. 31(8):1788–1795.
  • Keir HR, Chalmers JD. 2022. Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy. Eur Respir Rev. 31:210241.
  • Kimura I, Kagawa S, Tsuneki H, Tanaka K, Nagashima F. 2022. Multitasking bamboo leaf-derived compounds in prevention of infectious, inflammatory, atherosclerotic, metabolic, and neuropsychiatric diseases. Pharmacol Ther. 235:108159.
  • Kobiyama K, Ley K. 2018. Atherosclerosis. Circ Res. 123(10):1118–1120.
  • Koeth RA, Lam-Galvez BR, Kirsop J, Wang Z, Levison BS, Gu X, Copeland MF, Bartlett D, Cody DB, Dai HJ, et al. 2019. l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans. J Clin Invest. 129(1):373–387.
  • Li W, Zhi W, Liu F, Zhao J, Yao Q, Niu X. 2018. Paeoniflorin inhibits VSMCs proliferation and migration by arresting cell cycle and activating HO-1 through MAPKs and NF-κB pathway. Int Immunopharmacol. 54:103–111.
  • Lin YP, Fu SN, Li XP, Wang MM, Fang QL, Qiao X, Yan Q, Hua Y. 2022. Two novel flavonoids with lipid-lowering activity from Yi medicine Shekaqi. Chem Biodivers. 19:e202200363.
  • Liu J, Zhang W, Li Y, Li X, Li Y, Guo F. 2022. Flavonoids extract from the seeds of Psoralea corylifolia L. (PFE) alleviates atherosclerosis in high-fat diet-induced LDLR(−/−) mice. Phytomedicine. 98:153983.
  • Mahtta D, Lee MT, Ramsey DJ, Akeroyd JM, Krittanawong C, Khan SU, Sinh P, Alam M, Garratt KN, Schofield RS, et al. 2022. Significant facility-level variation in utilization of and adherence with secondary prevention therapies among patients with premature atherosclerotic cardiovascular disease: insights from the VITAL (Veterans wIth premaTure AtheroscLerosis) Registry7. Cardiovasc Drugs Ther. 36(1):93–102.
  • Moslehi A, Hamidi-Zad Z. 2018. Role of SREBPs in liver diseases: a mini-review. J Clin Transl Hepatol. 6(3):332–338.
  • Pan X, Wan R, Wang Y, Liu S, He Y, Deng B, Luo S, Chen Y, Wen L, Hong T, et al. 2022. Salvianolic acid B inhibiting chemically and mechanically activated Piezo1 channels as a mechanism for ameliorating atherosclerosis. Br J Pharmacol. 179(14):3778–3814.
  • Pérez-Belmonte LM, Moreno-Santos I, Cabrera-Bueno F, Sánchez-Espín G, Castellano D, Such M, Crespo-Leiro MG, Carrasco-Chinchilla F, Alonso-Pulpón L, López-Garrido M, et al. 2017. Expression of sterol regulatory element-binding proteins in epicardial adipose tissue in patients with coronary artery disease and diabetes mellitus: preliminary study. Int J Med Sci. 14(3):268–274.
  • Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D. 1997. GeneCards: integrating information about genes, proteins and diseases. Trends Genet. 13(4):163.
  • Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, et al. 2020. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 76(25):2982–3021.
  • Ru J, Li P, Wang J, Zhou W, Li B, Huang C, Li P, Guo Z, Tao W, Yang Y, et al. 2014. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 6(1):13.
  • Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. 2003. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13(11):2498–2504.
  • Solanki A, Bhatt LK, Johnston TP. 2018. Evolving targets for the treatment of atherosclerosis. Pharmacol Ther. 187:1–12.
  • Soppert J, Lehrke M, Marx N, Jankowski J, Noels H. 2020. Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting. Adv Drug Deliv Rev. 159:4–33.
  • Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, et al. 2017. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 45(D1):D362–D368.
  • Xu X, Zhang W, Huang C, Li Y, Yu H, Wang Y, Duan J, Ling Y. 2012. A novel chemometric method for the prediction of human oral bioavailability. Int J Mol Sci. 13(6):6964–6982.
  • Xu YH, Zhao LJ, Li Y. 2009. Alisol B acetate induces apoptosis of SGC7901 cells via mitochondrial and phosphatidylinositol 3-kinases/Akt signaling pathways. World J Gastroenterol. 15(23):2870–2877.
  • Zeng Q, Li L, Siu W, Jin Y, Cao M, Li W, Chen J, Cong W, Ma M, Chen K, et al. 2019. A combined molecular biology and network pharmacology approach to investigate the multi-target mechanisms of Chaihu Shugan San on Alzheimer’s disease. Biomed Pharmacother. 120:109370.
  • Zhang R, Zhu X, Bai H, Ning K. 2019. Network pharmacology databases for traditional Chinese medicine: review and assessment. Front Pharmacol. 10:123.
  • Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK. 2019. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 10(1):1523.
  • Zhu C, Cai T, Jin Y, Chen J, Liu G, Xu N, Shen R, Chen Y, Han L, Wang S, et al. 2020. Artificial intelligence and network pharmacology based investigation of pharmacological mechanism and substance basis of Xiaokewan in treating diabetes. Pharmacol Res. 159:104935.
  • Zhu B, Zhai Y, Ji M, Wei Y, Wu J, Xue W, Tao WW, Wu H. 2020. Alisma orientalis beverage treats atherosclerosis by regulating gut microbiota in ApoE−/− mice. Front Pharmacol. 11:570555.